1-20 of 23
Margalit B. Mokyr
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4755: Importance of an induction dose to the immunogenicity of cancer vaccines: A reverse translational study

David A. Berd, Donald Braun, Margalit B. Mokyr
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 4755.
https://doi.org/10.1158/1538-7445.AM10-4755
Published: 15 April 2010
View article titled, Abstract 4755: Importance of an induction dose to the immunogenicity of cancer vaccines: A reverse translational study
Journal Articles

Talactoferrin Alfa, a novel immunomodulatory agent with anti-cancer activity in phase II clinical trials.

Atul Varadhachary, Michela Spadaro, Jose Engelmayer, Claudia Curcio, Paul Blezinger, Margalit B. Mokyr, Yenyun Wang, Ve ’ted’ Valli, Guido Forni, Federica Pericle
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1311.
Published: 15 April 2006
View article titled, Talactoferrin Alfa, a novel immunomodulatory agent with anti-cancer activity in phase II clinical trials.
Journal Articles

Realization of the Therapeutic Potential of CTLA-4 Blockade in Low-Dose Chemotherapy-treated Tumor-bearing Mice

Margalit B. Mokyr, Tatiana Kalinichenko, Leonid Gorelik, Jeffrey A. Bluestone
Journal: Cancer Research
Cancer Res (1998) 58 (23): 5301–5304.
Published: 01 December 1998
View article titled, Realization of the Therapeutic Potential of CTLA-4 Blockade in Low-Dose Chemotherapy-treated Tumor-bearing Mice
Open the PDF for Realization of the Therapeutic Potential of CTLA-4 Blockade in Low-Dose Chemotherapy-treated Tumor-bearing Mice in another window
Journal Articles

Advantages of Adoptive Chemoimmunotherapy with Polyethylene Glycol-cultured, Antigen-activated, Tumor-infiltrated Spleen Cells for the Complete Eradication of Lethal MOPC-315 Plasmacytomas

Maribeth Laude, Katherine L. Siessmann, Margalit B. Mokyr, Sheldon Dray
Journal: Cancer Research
Cancer Res (1991) 51 (17): 4516–4522.
Published: 01 September 1991
View article titled, Advantages of Adoptive Chemoimmunotherapy with Polyethylene Glycol-cultured, Antigen-activated, Tumor-infiltrated Spleen Cells for the Complete Eradication of Lethal MOPC-315 Plasmacytomas
Open the PDF for Advantages of Adoptive Chemoimmunotherapy with Polyethylene Glycol-cultured, Antigen-activated, Tumor-infiltrated Spleen Cells for the Complete Eradication of Lethal MOPC-315 Plasmacytomas in another window
Journal Articles

Importance of Tumor-specific Cytotoxic CD8+ T-Cells in Eradication of a Large Subcutaneous MOPC-315 Tumor following Low-Dose Melphalan Therapy

Blaine Y. Takesue, Joseph M. Pyle, Margalit B. Mokyr
Journal: Cancer Research
Cancer Res (1990) 50 (23): 7641–7649.
Published: 01 December 1990
View article titled, Importance of Tumor-specific Cytotoxic CD8<sup>+</sup> T-Cells in Eradication of a Large Subcutaneous MOPC-315 Tumor following Low-Dose Melphalan Therapy
Open the PDF for Importance of Tumor-specific Cytotoxic CD8<sup>+</sup> T-Cells in Eradication of a Large Subcutaneous MOPC-315 Tumor following Low-Dose Melphalan Therapy in another window
Journal Articles

Lysis of Antigenically Unrelated Tumor Cells Mediated by Lyt 2+ Splenic T-Cells from Melphalan-cured MOPC-315 Tumor Bearers

Edward Barker, James A. Wise, Sheldon Dray, Margalit B. Mokyr
Journal: Cancer Research
Cancer Res (1989) 49 (18): 5007–5015.
Published: 01 September 1989
View article titled, Lysis of Antigenically Unrelated Tumor Cells Mediated by Lyt 2<sup>+</sup> Splenic T-Cells from Melphalan-cured MOPC-315 Tumor Bearers
Open the PDF for Lysis of Antigenically Unrelated Tumor Cells Mediated by Lyt 2<sup>+</sup> Splenic T-Cells from Melphalan-cured MOPC-315 Tumor Bearers in another window
Journal Articles

Importance of Lyt 2+ T-Cells in the Curative Effectiveness of a Low Dose of Melphalan for Mice Bearing a Large MOPC-315 Tumor

Margalit B. Mokyr, Edward Barker, Larry M. Weiskirch, Blaine Y. Takesue, Joseph M. Pyle
Journal: Cancer Research
Cancer Res (1989) 49 (16): 4597–4606.
Published: 01 August 1989
View article titled, Importance of Lyt 2<sup>+</sup> T-Cells in the Curative Effectiveness of a Low Dose of Melphalan for Mice Bearing a Large MOPC-315 Tumor
Open the PDF for Importance of Lyt 2<sup>+</sup> T-Cells in the Curative Effectiveness of a Low Dose of Melphalan for Mice Bearing a Large MOPC-315 Tumor in another window
Journal Articles

Enhancement of the Effectiveness of Lyt-2+ T-Cells for Adoptive Chemoimmunotherapy by Short-Term Exposure of Tumor-bearer Spleen Cells to Polyethylene Glycol and/or Melphalan

James A. Wise, Margalit B. Mokyr, Sheldon Dray
Journal: Cancer Research
Cancer Res (1989) 49 (13): 3613–3619.
Published: 01 July 1989
View article titled, Enhancement of the Effectiveness of Lyt-2<sup>+</sup> T-Cells for Adoptive Chemoimmunotherapy by Short-Term Exposure of Tumor-bearer Spleen Cells to Polyethylene Glycol and/or Melphalan
Open the PDF for Enhancement of the Effectiveness of Lyt-2<sup>+</sup> T-Cells for Adoptive Chemoimmunotherapy by Short-Term Exposure of Tumor-bearer Spleen Cells to Polyethylene Glycol and/or Melphalan in another window
Journal Articles

Interleukin 2 Requirement for the in Vitro Generation of Antitumor Cytotoxicity by Thymocytes from Melphalan-cured MOPC-315 Tumor Bearers

Margalit B. Mokyr, Mary M. Bartik, Mi-Chung Ahn
Journal: Cancer Research
Cancer Res (1989) 49 (4): 870–876.
Published: 01 February 1989
View article titled, Interleukin 2 Requirement for the <em>in Vitro</em> Generation of Antitumor Cytotoxicity by Thymocytes from Melphalan-cured MOPC-315 Tumor Bearers
Open the PDF for Interleukin 2 Requirement for the <em>in Vitro</em> Generation of Antitumor Cytotoxicity by Thymocytes from Melphalan-cured MOPC-315 Tumor Bearers in another window
Journal Articles

Importance of Lyt-2+ T-Cells in the Resistance of Melphalan-cured MOPC-315 Tumor Bearers to a Challenge with MOPC-315 Tumor Cells

Edward Barker, Margalit B. Mokyr
Journal: Cancer Research
Cancer Res (1988) 48 (17): 4834–4842.
Published: 01 September 1988
View article titled, Importance of Lyt-2<sup>+</sup> T-Cells in the Resistance of Melphalan-cured MOPC-315 Tumor Bearers to a Challenge with MOPC-315 Tumor Cells
Open the PDF for Importance of Lyt-2<sup>+</sup> T-Cells in the Resistance of Melphalan-cured MOPC-315 Tumor Bearers to a Challenge with MOPC-315 Tumor Cells in another window
Journal Articles

Melphalan-induced Enhancement of Antitumor Immune Reactivity in Thymocytes of Adult BALB/c Mice Bearing a Large MOPC-315 Tumor

Mary M. Bartik, Blaine Y. Takesue, Margalit B. Mokyr
Journal: Cancer Research
Cancer Res (1987) 47 (18): 4848–4855.
Published: 01 September 1987
View article titled, Melphalan-induced Enhancement of Antitumor Immune Reactivity in Thymocytes of Adult BALB/c Mice Bearing a Large MOPC-315 Tumor
Open the PDF for Melphalan-induced Enhancement of Antitumor Immune Reactivity in Thymocytes of Adult BALB/c Mice Bearing a Large MOPC-315 Tumor in another window
Journal Articles

Ability of Cyclophosphamide in the Absence of Cross-Linking Activity to Exert the Immunomodulatory Effect Required for the Cure of Mice Bearing a Large MOPC-315 Tumor

Margalit B. Mokyr, Robert B. Brundrett, Michael Colvin, Sheldon Dray
Journal: Cancer Research
Cancer Res (1986) 46 (7): 3313–3320.
Published: 01 July 1986
View article titled, Ability of Cyclophosphamide in the Absence of Cross-Linking Activity to Exert the Immunomodulatory Effect Required for the Cure of Mice Bearing a Large MOPC-315 Tumor
Open the PDF for Ability of Cyclophosphamide in the Absence of Cross-Linking Activity to Exert the Immunomodulatory Effect Required for the Cure of Mice Bearing a Large MOPC-315 Tumor in another window
Journal Articles

Some Characteristics of the Cyclophosphamide-induced Immunopotentiating Cells in the Spleen of Mice Bearing a Large MOPC-315 Tumor

Margalit B. Mokyr, Qing-Wei Ye
Journal: Cancer Research
Cancer Res (1985) 45 (10): 4932–4939.
Published: 01 October 1985
View article titled, Some Characteristics of the Cyclophosphamide-induced Immunopotentiating Cells in the Spleen of Mice Bearing a Large MOPC-315 Tumor
Open the PDF for Some Characteristics of the Cyclophosphamide-induced Immunopotentiating Cells in the Spleen of Mice Bearing a Large MOPC-315 Tumor in another window
Journal Articles

Cyclophosphamide-induced Appearance of Immunopotentiating T-Cells in the Spleens of Mice Bearing a Large MOPC-315 Tumor

Qing-Wei Ye, Margalit B. Mokyr
Journal: Cancer Research
Cancer Res (1984) 44 (9): 3873–3879.
Published: 01 September 1984
View article titled, Cyclophosphamide-induced Appearance of Immunopotentiating T-Cells in the Spleens of Mice Bearing a Large MOPC-315 Tumor
Open the PDF for Cyclophosphamide-induced Appearance of Immunopotentiating T-Cells in the Spleens of Mice Bearing a Large MOPC-315 Tumor in another window
Journal Articles

Some Advantages of Curing Mice Bearing a Large Subcutaneous MOPC-315 Tumor with a Low Dose Rather Than a High Dose of Cyclophosphamide

Margalit B. Mokyr, Sheldon Dray
Journal: Cancer Research
Cancer Res (1983) 43 (7): 3112–3119.
Published: 01 July 1983
View article titled, Some Advantages of Curing Mice Bearing a Large Subcutaneous MOPC-315 Tumor with a Low Dose Rather Than a High Dose of Cyclophosphamide
Open the PDF for Some Advantages of Curing Mice Bearing a Large Subcutaneous MOPC-315 Tumor with a Low Dose Rather Than a High Dose of Cyclophosphamide in another window
Journal Articles

Mode of Action of Polyethylene Glycol 6000 in Potentiating the in Vitro Generation of Antitumor Cytotoxicity by MOPC-315 Tumor Bearer Spleen Cells

Margalit B. Mokyr, Donna Przepiorka, Sheldon Dray
Journal: Cancer Research
Cancer Res (1982) 42 (7): 2537–2543.
Published: 01 July 1982
View article titled, Mode of Action of Polyethylene Glycol 6000 in Potentiating the <em>in Vitro</em> Generation of Antitumor Cytotoxicity by MOPC-315 Tumor Bearer Spleen Cells
Open the PDF for Mode of Action of Polyethylene Glycol 6000 in Potentiating the <em>in Vitro</em> Generation of Antitumor Cytotoxicity by MOPC-315 Tumor Bearer Spleen Cells in another window
Journal Articles

Role of Antitumor Immunity in Cyclophosphamide-induced Rejection of Subcutaneous Nonpalpable MOPC-315 Tumors

Margalit B. Mokyr, James C. D. Hengst, Sheldon Dray
Journal: Cancer Research
Cancer Res (1982) 42 (3): 974–979.
Published: 01 March 1982
View article titled, Role of Antitumor Immunity in Cyclophosphamide-induced Rejection of Subcutaneous Nonpalpable MOPC-315 Tumors
Open the PDF for Role of Antitumor Immunity in Cyclophosphamide-induced Rejection of Subcutaneous Nonpalpable MOPC-315 Tumors in another window
Journal Articles

Cooperation between Cyclophosphamide Tumoricidal Activity and Host Antitumor Immunity in the Cure of Mice Bearing Large MOPC-315 Tumors

James C. D. Hengst, Margalit B. Mokyr, Sheldon Dray
Journal: Cancer Research
Cancer Res (1981) 41 (6): 2163–2167.
Published: 01 June 1981
View article titled, Cooperation between Cyclophosphamide Tumoricidal Activity and Host Antitumor Immunity in the Cure of Mice Bearing Large MOPC-315 Tumors
Open the PDF for Cooperation between Cyclophosphamide Tumoricidal Activity and Host Antitumor Immunity in the Cure of Mice Bearing Large MOPC-315 Tumors in another window
Journal Articles

Effect of Polyethylene Glycol 6000 on the Generation of Antitumor Cytotoxicity in MOPC-315 Tumor Bearer Spleen Cells Cultured in the Presence or Absence of Inactivated Stimulator Tumor Cells

Donna Przepiorka, Margalit B. Mokyr, Sheldon Dray
Journal: Cancer Research
Cancer Res (1980) 40 (12): 4565–4570.
Published: 01 December 1980
View article titled, Effect of Polyethylene Glycol 6000 on the Generation of Antitumor Cytotoxicity in MOPC-315 Tumor Bearer Spleen Cells Cultured in the Presence or Absence of Inactivated Stimulator Tumor Cells
Open the PDF for Effect of Polyethylene Glycol 6000 on the Generation of Antitumor Cytotoxicity in MOPC-315 Tumor Bearer Spleen Cells Cultured in the Presence or Absence of Inactivated Stimulator Tumor Cells in another window
Journal Articles

Importance of Timing in Cyclophosphamide Therapy of MOPC-315 Tumor-bearing Mice

James C. D. Hengst, Margalit B. Mokyr, Sheldon Dray
Journal: Cancer Research
Cancer Res (1980) 40 (7): 2135–2141.
Published: 01 July 1980
View article titled, Importance of Timing in Cyclophosphamide Therapy of MOPC-315 Tumor-bearing Mice
Open the PDF for Importance of Timing in Cyclophosphamide Therapy of MOPC-315 Tumor-bearing Mice in another window